PREOPERATIVE HEMODILUTION WITH ERYTHROCYTAPHERESIS - A TOOL FOR AUTOLOGOUS BLOOD-TRANSFUSION IN NEUROSURGERY

被引:2
|
作者
KALFON, F
BEAUMONT, JL
FOURNEL, JJ
VIARS, P
机构
[1] Département d'Anesthésie-Réanimation, Groupe Hospitalier Pitié-Salpêtrière, 75561 Paris Cedex 13, 47-83, boulevard de l'Hôpital
[2] Centre d'Hémobiologie-Transfusion, Groupe Hospitalier Pitié-Salpêtrière, 75561 Paris Cedex 13, 47-83, boulevard de l'Hôpital
来源
关键词
Anesthésie (selon chirurgie) : neurologique; Hémodilution : érythrocytaphérèse; Transfusion;
D O I
10.1016/S0750-7658(05)80917-7
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Autologous blood transfusion techniques have been devised in order to decrease the risk of homologous transfusion-related complications. In neurosurgery, preoperative autologous blood collection is difficult because of the rather short time interval before surgery, as weel as the risk of increasing cerebral oedema or intracranial hypertension. Therefore erythrocytapheresis has been performed the day before surgery as a preoperative haemodilution in 33 patients, using a discontinuous flow cell separator (PCS + Heamonetics). Patients with anaemia, unstable cardiovascular condition, infections, malignant tumor with a bad prognosis, or a poor peripheral venous status were not included. The mean volume of collected red cells was 526 +/- 176 mt, allowing a minimal colloid perfusion adjusted on this volume, with a simultaneous restitution of plasma and platelets. For a mean peroperative estimated blood loss of 1 040 +/- 52 mt, a homologous blood transfusion was avoided in 29 patients (88 %). Four patients who underwent meningioma surgery received homologous red cells units in addition to their autologous blood. Two patients did not require any transfusion. Finally, 88 % of autologous red cells units were readministered and 8 units were not retransfused. Preoperative erythrocytapheresis has proven to be a very simple and well tolerated technique. It can be considered for elective neurosurgery, when the time delay before surgery is short and when the blood loss is anticipated as to be moderate. It may also be associated with iterative autologous blood donation programme or the peroperative use of a cell saver.
引用
收藏
页码:798 / 806
页数:9
相关论文
共 50 条